[go: up one dir, main page]

SE8701294L - Hiv-peptid - Google Patents

Hiv-peptid

Info

Publication number
SE8701294L
SE8701294L SE8701294A SE8701294A SE8701294L SE 8701294 L SE8701294 L SE 8701294L SE 8701294 A SE8701294 A SE 8701294A SE 8701294 A SE8701294 A SE 8701294A SE 8701294 L SE8701294 L SE 8701294L
Authority
SE
Sweden
Prior art keywords
hiv
peptide
cys
leu
gln
Prior art date
Application number
SE8701294A
Other languages
English (en)
Other versions
SE8701294D0 (sv
SE468181B (sv
Inventor
A Vahlne
Original Assignee
Virovahl Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virovahl Sa filed Critical Virovahl Sa
Priority to SE8701294A priority Critical patent/SE468181B/sv
Publication of SE8701294D0 publication Critical patent/SE8701294D0/sv
Priority to NO881151A priority patent/NO881151L/no
Priority to ZA882095A priority patent/ZA882095B/xx
Priority to FI881418A priority patent/FI881418L/fi
Priority to ES8800920A priority patent/ES2013328A6/es
Priority to NZ224046A priority patent/NZ224046A/xx
Priority to CA000562531A priority patent/CA1336473C/en
Priority to DK164088A priority patent/DK164088A/da
Priority to SU884355648A priority patent/RU1802871C/ru
Priority to AU13807/88A priority patent/AU606928B2/en
Priority to EP19880850105 priority patent/EP0284587A3/en
Publication of SE8701294L publication Critical patent/SE8701294L/sv
Priority to ZA892301A priority patent/ZA892301B/xx
Publication of SE468181B publication Critical patent/SE468181B/sv
Priority to CA000616876A priority patent/CA1338028C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE8701294A 1987-03-27 1987-03-27 Hiv-1 gp41 peptid, vaccin och antigen innehaallande peptiden jaemte diagnostiskt test med peptiden SE468181B (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE8701294A SE468181B (sv) 1987-03-27 1987-03-27 Hiv-1 gp41 peptid, vaccin och antigen innehaallande peptiden jaemte diagnostiskt test med peptiden
NO881151A NO881151L (no) 1987-03-27 1988-03-16 Syntetisk hiv-1-antigen.
ZA882095A ZA882095B (en) 1987-03-27 1988-03-24 Synthetic peptide antigens for the detection of hiv-1 infection
FI881418A FI881418L (fi) 1987-03-27 1988-03-24 Syntetiska peptid antigener foer faststaellande av hiv-1 infektion.
AU13807/88A AU606928B2 (en) 1987-03-27 1988-03-25 Synthetic peptide antigens for the detection of hiv-1 infection
CA000562531A CA1336473C (en) 1987-03-27 1988-03-25 Synthetic peptide antigens for the detection of hiv-1 infection
NZ224046A NZ224046A (en) 1987-03-27 1988-03-25 Hiv antigenic peptide fragments and their use
ES8800920A ES2013328A6 (es) 1987-03-27 1988-03-25 Un metodo para detectar anticuerpos contra antigenos hiv-1.
DK164088A DK164088A (da) 1987-03-27 1988-03-25 Syntetiske peptidantigener til paavisning af hiv-1-infektion
SU884355648A RU1802871C (ru) 1987-03-27 1988-03-25 Способ определени антител к Н @ V - 1
EP19880850105 EP0284587A3 (en) 1987-03-27 1988-03-28 Synthetic peptide antigens for the detection of hiv-1 infection
ZA892301A ZA892301B (en) 1987-03-27 1989-03-29 Synthetic peptide antigens for the detection of htlv-1 infection
CA000616876A CA1338028C (en) 1987-03-27 1994-06-09 Synthetic peptide antigens for the detection of hiv-1 infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8701294A SE468181B (sv) 1987-03-27 1987-03-27 Hiv-1 gp41 peptid, vaccin och antigen innehaallande peptiden jaemte diagnostiskt test med peptiden

Publications (3)

Publication Number Publication Date
SE8701294D0 SE8701294D0 (sv) 1987-03-27
SE8701294L true SE8701294L (sv) 1988-09-28
SE468181B SE468181B (sv) 1992-11-16

Family

ID=20368020

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8701294A SE468181B (sv) 1987-03-27 1987-03-27 Hiv-1 gp41 peptid, vaccin och antigen innehaallande peptiden jaemte diagnostiskt test med peptiden

Country Status (2)

Country Link
SE (1) SE468181B (sv)
ZA (1) ZA882095B (sv)

Also Published As

Publication number Publication date
SE8701294D0 (sv) 1987-03-27
SE468181B (sv) 1992-11-16
ZA882095B (en) 1989-10-25

Similar Documents

Publication Publication Date Title
NO881719D0 (no) Syntetisk hiv-2-antigen.
DK614987A (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
FI910497A0 (fi) Nytt virus vid infektioes bursalsjukdom.
ES2016426A6 (es) Un procedimiento para detectar la presencia de anticuerpos frente a virus del sida en el suero humano.
NO881151L (no) Syntetisk hiv-1-antigen.
ATE82509T1 (de) Orale impfstoffe.
DE69013950D1 (de) Monoklonaler Antikörper zur Unterscheidung HIV-2-seropositiver von HIV-1-seropositiven Individuen.
DK0755684T3 (da) Vaccinekonjugat
ATE119203T1 (de) Monoklonale antikörper von mäusen gegen das gp41 protein von menschlichem immunmangelsyndrom- virus.
ATE90689T1 (de) Fragment von hepatitis-b-innenkoerperantigen.
SE8701294L (sv) Hiv-peptid
ATE4282T1 (de) Verfahren zur herstellung von toxoplasmenbereitungen fuer die toxoplasmosediagnose und die so hergestellten bereitungen.
NZ235474A (en) Virus capable of inducing infectious bursal disease; assay and vaccine
WO1989009227A3 (fr) Peptides pf10 a pf19 d'un retrovirus hiv - procede de synthese de ces peptides - leur utilisation notamment pour le diagnostic
NO881661D0 (no) Humane rhinoviruspeptider.
LV10626A (lv) Peptidi
GB916455A (en) Non-toxic antigens and process for producing same
ATE123036T1 (de) Methode zur in vitro diagnose von hiv-1 virus infektionen.
RU95101596A (ru) Штамм "м-92" инфекционной бурсальной болезни индеек - семейство birnoviridae
FI883765L (fi) Antikroppar mot biologiskt aktiva polypeptider och deras anvaendning vid diagnostiska foerfaranden.
ES2009280A6 (es) Un metodo para detectar anticuerpos al virus hiv-1 en una muestra.
ZA88310B (en) Peptides capable of being recognized by antibodies induced against human immunodeficiency retrovirus(hiv-virus),their applications for diagnosis of infections caused by some of these viruses and,in case,to vaccination against aids

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8701294-4

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8701294-4

Format of ref document f/p: F